<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39452791</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2409-9279</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Methods and protocols</Title><ISOAbbreviation>Methods Protoc</ISOAbbreviation></Journal><ArticleTitle>Oral Pre-Exposure Prophylaxis Innovative Interventions among Adolescent Girls and Young Women in South Africa: A Protocol Paper.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">77</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/mps7050077</ELocationID><Abstract><AbstractText>Although South Africa was the first country to register and roll out oral pre-exposure prophylaxis (PrEP) biomedical human immunodeficiency virus (HIV) prevention intervention in sub-Saharan Africa (SSA), its uptake remains low, particularly among adolescent girls and young women (AGYW). The uptake of PrEP may have worsened during the Coronavirus disease 2019 (COVID-19) pandemic. Some innovative interventions to improve PrEP uptake among AGYW have been implemented. This study aims to evaluate the effectiveness of PrEP innovative interventions implemented during COVID-19 towards reducing the risk of HIV infection among AGYW in South Africa. An exploratory, descriptive design will be conducted to carry out four study objectives. Firstly, to carry out a systematic review of innovative PrEP interventions implemented during COVID-19 in SSA countries. Secondly, to conduct a stakeholder analysis to identify PrEP stakeholders and interview them on their views on the implemented interventions. Thirdly, to assess the implementation outcomes of the innovative interventions using document reviews and Consolidated Framework for Implementation Research. Fourthly, to develop a framework for an improved PrEP service delivery among AGYW. Qualitative data will be captured in ATLAS.ti software (Technical University, Berlin, Germany) version 23 and analysed via thematic analysis. A statistical software package (STATA) version 18 (College Station, TX, USA) will be used to capture quantitative data and analyse them via descriptive analysis. The generated evidence will be used towards the development of framework, guidelines, and policies to strengthen the uptake of, scale-up, and adherence to PrEP among AGYW.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olifant</LastName><ForeName>Lerato Lucia</ForeName><Initials>LL</Initials><Identifier Source="ORCID">0000-0002-4564-0760</Identifier><AffiliationInfo><Affiliation>Faculty of Health Sciences, South African Medical Research Council/University of Johannesburg (SAMRC/UJ) Pan African Centre for Epidemics Research (PACER) Extramural Unit, Johannesburg 2006, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phalane</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, South African Medical Research Council/University of Johannesburg (SAMRC/UJ) Pan African Centre for Epidemics Research (PACER) Extramural Unit, Johannesburg 2006, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phaswana-Mafuya</LastName><ForeName>Refilwe Nancy</ForeName><Initials>RN</Initials><Identifier Source="ORCID">0000-0001-9387-0432</Identifier><AffiliationInfo><Affiliation>Faculty of Health Sciences, South African Medical Research Council/University of Johannesburg (SAMRC/UJ) Pan African Centre for Epidemics Research (PACER) Extramural Unit, Johannesburg 2006, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Methods Protoc</MedlineTA><NlmUniqueID>101720073</NlmUniqueID><ISSNLinking>2409-9279</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HIV/AIDS</Keyword><Keyword MajorTopicYN="N">South Africa</Keyword><Keyword MajorTopicYN="N">adolescent girls and young women</Keyword><Keyword MajorTopicYN="N">innovative interventions</Keyword><Keyword MajorTopicYN="N">pre-exposure prophylaxis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39452791</ArticleId><ArticleId IdType="pmc">PMC11510152</ArticleId><ArticleId IdType="doi">10.3390/mps7050077</ArticleId><ArticleId IdType="pii">mps7050077</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Strategic Plan for HIV, TB, and STIs (2023–2028)  [(accessed on 16 March 2024)].  Available online:  https://nsp.sanac.org.za/uploads/files/NSPn-for-HIV-TB-STIs-2023-2028-Draft3C.pdf.</Citation></Reference><Reference><Citation>Joint United Nations for HIV/AIDS Programmes (UNAIDS)  Fact Sheet: Global HIV Statistics. 2023.  [(accessed on 13 March 2024)].  Available online:  https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.</Citation></Reference><Reference><Citation>Statistics South Africa (Stats SA)  Mid-Year Population Estimates.  [(accessed on 16 March 2024)];2021  Available online:  https://www.statssa.gov.za/publications/P0302/P03022021.pdf.</Citation></Reference><Reference><Citation>Palanee-Phillips T., Rees H.V., Heller K.B., Ahmed K., Batting J., Beesham I., Heffron R., Justman J., Makkan H., Mastro T.D., et al. High HIV incidence among young women in South Africa: Data from a large prospective study. PLoS ONE. 2022;17:e0269317. doi: 10.1371/journal.pone.0269317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0269317</ArticleId><ArticleId IdType="pmc">PMC9165791</ArticleId><ArticleId IdType="pubmed">35657948</ArticleId></ArticleIdList></Reference><Reference><Citation>Celum C.L., Delany-Moretlwe S., Baeten J.M., van der Straten A., Hosek S., Bukusi E.A., McConnell M., Barnabas R.V., Bekker L.G. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: From efficacy trials to delivery. J. Int. AIDS Soc. 2019;22:e25298. doi: 10.1002/jia2.25298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jia2.25298</ArticleId><ArticleId IdType="pmc">PMC6643076</ArticleId><ArticleId IdType="pubmed">31328444</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson L.F., Dorrington R.E. Modelling the Impact of HIV in South Africa’s Provinces: 2021 Update. Centre for Infectious Disease Epidemiology and Research, University of Cape Town; Cape Town, South Africa: 2021.</Citation></Reference><Reference><Citation>Centres for Disease Control and Prevention (CDC)  Pre-Exposure Prophylaxis (PrEP)  [(accessed on 13 July 2023)];2022  Available online:  https://www.cdc.gov/hiv/risk/prep/index.html.</Citation></Reference><Reference><Citation>Pillay D., Stankevitz K., Lanham M., Ridgeway K., Murire M., Briedenhann E., Jenkins S., Subedar H., Hoke T., Mullick S. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS ONE. 2020;15:e0228620. doi: 10.1371/journal.pone.0228620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0228620</ArticleId><ArticleId IdType="pmc">PMC7192496</ArticleId><ArticleId IdType="pubmed">32352969</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald J., Estcourt C.S., Flowers P., Nandwani R., Frankis J., Young I., Clutterbuck D., Dalrymple J., McDaid L., Steedman N., et al. Improving HIV pre-exposure prophylaxis (PrEP) adherence and retention in care: Process evaluation and recommendation. PLoS ONE. 2023;18:e0292289. doi: 10.1371/journal.pone.0292289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0292289</ArticleId><ArticleId IdType="pmc">PMC10561843</ArticleId><ArticleId IdType="pubmed">37812636</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapsoba J.D., Cover J., Obong’o C., Brady M., Cressey T.R., Mori K., Okomo G., Kariithi E., Obanda R., Oluoch-Madiang D., et al. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study. PLoS Med. 2022;19:e1004097. doi: 10.1371/journal.pmed.1004097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004097</ArticleId><ArticleId IdType="pmc">PMC9521917</ArticleId><ArticleId IdType="pubmed">36095005</ArticleId></ArticleIdList></Reference><Reference><Citation>Celum C.L., Gill K., Morton J.F., Stein G., Myers L., Thomas K.K., McConnell M., van der Straten A., Baeten J.M., Duyver M., et al. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: A randomized trial. J. Int. AIDS Soc. 2020;23:e25636. doi: 10.1002/jia2.25636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jia2.25636</ArticleId><ArticleId IdType="pmc">PMC7695999</ArticleId><ArticleId IdType="pubmed">33247553</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau E., Katz A.W., O’Rourke S., Bekker L.G., Delany-Moretlwe S., Bukusi E., Travill D., Omollo V., Morton J.F., O’Malley G., et al. Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya. PLoS ONE. 2021;16:e0258542. doi: 10.1371/journal.pone.0258542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0258542</ArticleId><ArticleId IdType="pmc">PMC8516266</ArticleId><ArticleId IdType="pubmed">34648589</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed J.B., Shrestha P., Were D., Chakare T., Mutegi J., Wakhutu B., Musau A., Nonyana N.M., Christensen A., Patel R., et al. HIV PrEP is more than ART-lite: Longitudinal study of real-world PrEP services data identifies missing measures meaningful to HIV prevention programming. J. Int. AIDS Soc. 2021;24:e25827. doi: 10.1002/jia2.25827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jia2.25827</ArticleId><ArticleId IdType="pmc">PMC8516366</ArticleId><ArticleId IdType="pubmed">34648678</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P., Sato K., Bhandari N., Kanagasabai U., Schelar E., Cooney C., Eakle R., Klucking S., Toiv N., Saul J. From policy to practice uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President’s Emergency Plan for AIDS Relief-supported countries, 2017–2020. AIDS. 2022;36((Suppl. S1)):S15–S26. doi: 10.1097/QAD.0000000000003103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000003103</ArticleId><ArticleId IdType="pubmed">35766572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayesu I., Mayanja Y., Nakirijja C., Machira Y.W., Price M., Seeley J., Siu G. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers. BMC Women’s Health. 2022;22:440. doi: 10.1186/s12905-022-02018-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12905-022-02018-z</ArticleId><ArticleId IdType="pmc">PMC9648457</ArticleId><ArticleId IdType="pubmed">36357920</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintye J., O’Malley G., Kinuthia J., Abuna F., Escudero J.N., Mugambi M., Awuor M., Dollah A., Dettinger J.C., Kohler P., et al. Influences on early discontinuation and persistence of daily oral PrEP use among Kenyan adolescent girls and young women: A qualitative evaluation from a PrEP implementation program. JAIDS J. Acquir. Immune Defic. Syndr. 2021;86:e83–e89. doi: 10.1097/QAI.0000000000002587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002587</ArticleId><ArticleId IdType="pmc">PMC8935942</ArticleId><ArticleId IdType="pubmed">33273211</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  (2020) COVID-19: Operational Guidance for Maintaining Essential Health Services during an Outbreak. Interim Guidance 25 Match 2020.  [(accessed on 1 July 2022)].  Available online:  https://apps.who.int/iris/bitstream/handle/10665/331561/WHO-2019-nCoV-essential_health_services-2020.1-eng.pdf?sequence=1&amp;isAllowed=y.</Citation></Reference><Reference><Citation>Yao D., Hill N., Brown B., Gule D., Chabane M., Mcingana M., Willis K., Shiba V., Olawore O., Nel D., et al. The impact of COVID-19 restrictions on HIV prevention and treatment services for key populations in South Africa: An interrupted time series analysis. BMC Public Health. 2024;24:2386. doi: 10.1186/s12889-024-19679-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-024-19679-0</ArticleId><ArticleId IdType="pmc">PMC11370299</ArticleId><ArticleId IdType="pubmed">39223515</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey D.L., Bekker L.G., Mashele N., Gorbach P., Coates T.J., Myer L. PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa. Lancet HIV. 2020;7:e735. doi: 10.1016/S2352-3018(20)30226-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3018(20)30226-5</ArticleId><ArticleId IdType="pmc">PMC7398649</ArticleId><ArticleId IdType="pubmed">32758479</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization: Coronavirus Disease (COVID-19) 2020.  [(accessed on 1 July 2022)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.</Citation></Reference><Reference><Citation>Ramalingam B., Prabhu J. Innovation, Development and COVID-19: Challenges, Opportunities and Ways Forward.  [(accessed on 1 January 2024)];OECD. 2020 :1–4. Available online:  https://www.oecd-ilibrary.org/development/innovation-development-and-covid-19-challenges-opportunities-and-ways-forward_0c976158-en.</Citation></Reference><Reference><Citation>Kerzner M., De A.K., Yee R., Keating R., Djomand G., Stash S., Rana S., Kimmel A., Eakle R., Klucking S., et al. Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries. PLoS ONE. 2022;17:e0266280. doi: 10.1371/journal.pone.0266280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266280</ArticleId><ArticleId IdType="pmc">PMC8982838</ArticleId><ArticleId IdType="pubmed">35381024</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardim C.G., Zamani R., Akrami M. Evaluating the impact of the COVID-19 pandemic on accessing HIV services in South Africa: A systematic review. Int. J. Environ. Res. Public Health. 2022;19:11899. doi: 10.3390/ijerph191911899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191911899</ArticleId><ArticleId IdType="pmc">PMC9565529</ArticleId><ArticleId IdType="pubmed">36231201</ArticleId></ArticleIdList></Reference><Reference><Citation>Irungu E., Khoza N., Velloza J. Multi-level interventions to promote oral pre-exposure prophylaxis use among adolescent girls and young women: A review of recent research. Curr. HIV/AIDS Rep. 2021;18:490–499. doi: 10.1007/s11904-021-00576-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11904-021-00576-9</ArticleId><ArticleId IdType="pmc">PMC8557703</ArticleId><ArticleId IdType="pubmed">34719745</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Moher D. Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. J. Clin. Epidemiol. 2021;134:103–112. doi: 10.1016/j.jclinepi.2021.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2021.02.003</ArticleId><ArticleId IdType="pubmed">33577987</ArticleId></ArticleIdList></Reference><Reference><Citation>CASP Checklist  Critical Appraisal Checklist. 2022.  [(accessed on 1 July 2023)].  Available online:  https://casp-uk.net/casp-tools-checklists/</Citation></Reference><Reference><Citation>George J., Häsler B., Komba E.V., Sindato C., Rweyemamu M., Kimera S.I., Mlangwa J.E. Leveraging sub-national collaboration and influence for improving animal health surveillance and response: A stakeholder mapping in Tanzania. Front. Vet. Sci. 2021;8:738888. doi: 10.3389/fvets.2021.738888.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2021.738888</ArticleId><ArticleId IdType="pmc">PMC8710487</ArticleId><ArticleId IdType="pubmed">34966802</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenny S., Brannan J.M., Brannan G.D.  StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2023.  [(accessed on 1 February 2024)]. Qualitative Study. [Updated 2022 Sep 18] Available online:  https://www.ncbi.nlm.nih.gov/books/NBK470395/</Citation></Reference><Reference><Citation>The Bokone Bophirima (North-West) Provincial Implementation Plan on HIV, TB, and STIs (2017–2022)  [(accessed on 13 March 2024)].  Available online:  https://sanac.org.za/wp-content/uploads/2019/02/PIP_NorthWest_Final-1.pdf.</Citation></Reference><Reference><Citation>Dr Kenneth Kaunda District NW. Profile and Analysis: District Development Model.  [(accessed on 16 March 2024)];2020  Available online:  https://www.cogta.gov.za/ddm/wp-content/uploads/2020/08/DR-KK-Draft3.pdf.</Citation></Reference><Reference><Citation>Damschroder L.J., Reardon C.M., Widerquist M.A., Lowery J. The updated Consolidated Framework for Implementation Research is based on user feedback. Implement. Sci. 2022;17:75. doi: 10.1186/s13012-022-01245-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-022-01245-0</ArticleId><ArticleId IdType="pmc">PMC9617234</ArticleId><ArticleId IdType="pubmed">36309746</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>